Virology And Bacteriology Market Research 2025 - Global Industry Size, Share, Trends, Opportunity, And Forecast, 2020-2030F

(MENAFN- GlobeNewsWire - Nasdaq) The main market opportunities in the Global Virology and Bacteriology Market include addressing the rising prevalence of infectious diseases with advanced diagnostics, vaccines, and therapies. Innovations in AI and machine learning are enhancing drug discovery and diagnostics, presenting avenues for growth and efficiency improvements.

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "Virology and Bacteriology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets's offering.
The Global Virology and Bacteriology Market, valued at USD 2.73 Billion in 2024, is projected to experience a CAGR of 6.70% to reach USD 4.03 Billion by 2030

The Global Virology and Bacteriology Market encompasses products and services dedicated to understanding, diagnosing, preventing, and treating viral and bacterial infections, including diagnostic assays, vaccines, and therapeutic solutions. Market growth is principally driven by the increasing global prevalence of infectious diseases, substantial advancements in molecular diagnostics, and the persistent threat of antimicrobial resistance.
Key Market Drivers
The global virology and bacteriology market is significantly influenced by the rising prevalence of infectious diseases, which creates an urgent demand for advanced diagnostic and therapeutic solutions. The continuous emergence and resurgence of pathogens, such as *Mycobacterium tuberculosis*, necessitate sustained public health and clinical intervention efforts.

According to the World Health Organization, in November 2024, the Global Tuberculosis Report 2024 highlighted that approximately 8.2 million people were newly diagnosed with tuberculosis globally in 2023, an increase from 7.5 million in 2022, placing it as the leading infectious disease killer. This persistent burden drives the need for novel antimicrobials, efficient vaccines, and rapid diagnostic tools to detect infections and manage outbreaks, stimulating market expansion.
Key Market Challenges
A significant challenging factor impacting the Global Virology and Bacteriology Market is the substantial investment required for developing and commercializing novel antimicrobial agents and advanced diagnostic platforms. This financial barrier directly impedes the ability of companies to allocate sufficient resources towards exploratory research and late-stage clinical trials for new products.

The development of innovative solutions, particularly for emerging pathogens and drug-resistant strains, necessitates prolonged research cycles and complex testing, significantly escalating overall expenditure. Such high investment costs can deter smaller companies and limit the portfolio expansion of larger entities, consequently slowing the introduction of much-needed advancements into the market.
Key Market Trends
Artificial Intelligence and Machine Learning are significantly reshaping the global virology and bacteriology market, accelerating drug discovery and enhancing diagnostic precision. These technologies facilitate rapid analysis of vast biological datasets, optimizing therapeutic target identification and drug candidate selection.

According to AdvaMed, the medical technology association, a February 2024 report highlighted that over 80% of in-market medical technology products utilizing AI and machine learning perform diagnostic functions, demonstrating their critical role. This integration notably streamlines development timelines and reduces costs. For instance, in October 2025, Insilico Medicine advanced its AI-generated drug, Rentosertib, into Phase IIa clinical trials, underscoring AI's direct impact on novel therapy development.

Key Attributes:

Report Attribute	Details
No. of Pages	183
Forecast Period	2024 - 2030
Estimated Market Value (USD) in 2024	$2.73 Billion
Forecasted Market Value (USD) by 2030	$4.03 Billion
Compound Annual Growth Rate	6.7%
Regions Covered	Global

Report Scope:

Key Market Players Profiled:

• Fujirebio Diagnostics Inc.
• Cepheid Inc.
• DiaSorin S.p.A.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Scienion GmbH
• Grifols S.A.
• Qiagen N.V.
• Eiken Chemical Co. Ltd.
• Laboratory Corporation of America Holdings

By Technology:

• Molecular Diagnostics
• Immunoassays
• Diagnostic Imaging
• Information Technology

By End User:

• Hospitals
• Diagnostic Centers
• Research Laboratories
• Blood Banks

By Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN28112025004107003653ID1110409704